Literature DB >> 31735319

Hypertension and Heart Failure: Prevention, Targets, and Treatment.

Katherine E Di Palo1, Nicholas J Barone2.   

Abstract

Hypertension is possibly the most powerful, modifiable risk factor for the development of heart failure. Chronic hypertension drives cardiac remodeling within the left ventricle resulting in hypertensive heart disease, which ultimately manifests as heart failure. Early detection and appropriate management are necessary to prevent heart failure as well as other cardiovascular diseases. Achieving blood pressure goals in conjunction with using evidence-based treatments can improve clinical outcomes for patients with comorbid hypertension and heart failure.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; Hypertension; Pharmacotherapy; Risk reduction

Mesh：

Substances：

Year:  2020        PMID： 31735319     DOI： 10.1016/j.hfc.2019.09.001

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  32 in total

1.  Combined use of cardiopulmonary ultrasound in the diagnosis of pulmonary edema in patients with heart failure: a retrospective analysis.

Authors:  Mengjun Shen; Hongwei Chen; Yang Cong
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

2.  Blood Pressure and Blood Glucose Control and Associated Factors Among Adults with Hypertension at Three Public Hospitals in Southern Ethiopia.

Authors:  Mende Mensa Sorato; Majid Davari; Abbas Kebriaeezadeh; Nizal Sarrafzadegan; Tamiru Shibru
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-04-11

3.  Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.

Authors:  Qing-Qing Wu; Qi Yao; Tong-Tong Hu; Ying Wan; Qing-Wen Xie; Jin-Hua Zhao; Yuan Yuan; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2022-08-10       Impact factor: 7.169

4.  Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study.

Authors:  Xujuan Zheng; Juan Xiong; Yiqin Zhang; Liping Xu; Lina Zhou; Bin Zhao; Yuxin Wang
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

Review 5.  Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.

Authors:  Filippos Triposkiadis; Andrew Xanthopoulos; John Parissis; Javed Butler; Dimitrios Farmakis
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

6.  Antihypertensive Activity of Eucommia Ulmoides Oliv: Male Flower Extract in Spontaneously Hypertensive Rats.

Authors:  Zhen-Jiang Ding; Chao Liang; Xiao Wang; Xin Yao; Ruo-Han Yang; Zhan-Sheng Zhang; Jin-Jin He; Hong-Yan Du; Dong Fang; Qin Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-30       Impact factor: 2.629

7.  Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure.

Authors:  Wei Ren; Zhiqiang Luo; Fulu Pan; Jiali Liu; Qin Sun; Gang Luo; Raoqiong Wang; Haiyu Zhao; Baolin Bian; Xiao Xiao; Qingrong Pu; Sijin Yang; Guohua Yu
Journal:  PeerJ       Date:  2020-10-30       Impact factor: 2.984

8.  Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.

Authors:  Il Yong Chung; Jong Won Lee; Hyeong-Gon Moon; Kyung Hwan Shin; Wonshik Han; Byung Ho Son; Sei-Hyun Ahn; Dong-Young Noh
Journal:  Breast       Date:  2020-07-31       Impact factor: 4.380

9.  Hypertension in the United States Fire Service.

Authors:  Saeed U Khaja; Kevin C Mathias; Emilie D Bode; Donald F Stewart; Kepra Jack; Steven M Moffatt; Denise L Smith
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

10.  The correlation between neck circumference and risk factors in patients with hypertension: What matters.

Authors:  Yudan Zhang; Haixia Wu; Yilian Xu; Huang Qin; Cuizhen Lan; Wenzhen Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.